Gabriel Schnetzler Selected Research

Gabriel Schnetzler Research Topics

3	Erectile Dysfunction 09/2010 - 12/2008
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2022
2	Neoplasms (Cancer) 01/2022 - 01/2016
2	Malaria 11/2014 - 11/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Disease Progression 01/2022
1	Chronic Renal Insufficiency 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Infections 11/2014
1	Liver Diseases (Liver Disease) 11/2014
1	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2014
1	Hypertension (High Blood Pressure) 12/2009
1	Hyperlipidemias (Hyperlipidemia) 12/2009
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2009
1	Headache (Headaches) 12/2008
1	Flushing 12/2008
1	Aspergillosis 09/2006
1	Acute Kidney Injury (Acute Renal Failure) 09/2006

3	Sildenafil Citrate (Viagra)FDA Link 09/2010 - 12/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2022
2	Mefloquine (Lariam)FDA LinkGeneric 11/2014 - 11/2014
1	HhAntag691IBA 02/2022
1	continuous erythropoietin receptor activator FDA Link 01/2020
1	Rituximab (Mabthera)FDA Link 01/2016
1	alpha- 2- pyridinyl- 2,8- bis(trifluoromethyl)- 4- quinolinemethanolIBA 11/2014
1	proguanil drug combination atovaquone (malarone)FDA Link 11/2014
1	Antimalarials (Antimalarial Agents)IBA 11/2014
1	Amphotericin B (Amphotericin)FDA LinkGeneric 09/2006
1	Voriconazole (Vfend)FDA LinkGeneric 09/2006